Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High glucose-primed HUVEC-derived extracellular vesicles encapsulated in microgels boost diabetic ischaemic flap regeneration via HIF-1α/VEGF pathway.

Journal of nanobiotechnology·2026
Same author

Injectable chondroitin sulfate-glycosylated decellularized extracellular matrix microgels activate Wnt/β-Catenin signaling to promote functional muscle regeneration in VML.

Bioactive materials·2026
Same author

Hierarchical microtopology and phase-specific delivery functionally restore ultralong nerve continuity across species.

Science advances·2026
Same author

Development of a vascularized multi-organoid-on-a-chip to model the heart-islet axis in diabetic cardiomyopathy.

Bioactive materials·2026
Same author

Phosphatidylserine-everted erythrocyte membrane vesicles enhance efferocytosis and remodeling of vascular grafts.

Nature communications·2026
Same author

Betaine based organ preservation solution alleviates renal allograft I/R injury by protecting endothelial cells.

Regenerative biomaterials·2026

相关实验视频

Updated: May 16, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

表面诱导的水凝化抑制了血小板聚合.

Wenting Zheng1, Jie Gao, Lijie Song

  • 1State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin 300071, PR China.

Journal of the American Chemical Society
|December 18, 2012
PubMed
概括

一种新型的三化水凝器,Nap-FFG,在血小板上选择性地自我组装,抑制它们的聚合. 这一发现为分子凝在医学和疾病控制中的应用开辟了新的途径.

更多相关视频

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

相关实验视频

Last Updated: May 16, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

科学领域:

  • 生物材料科学 生物材料科学
  • 纳米技术 纳米技术
  • 生物化学 生物化学

背景情况:

  • 血小板聚合在血栓形成和血液静止中至关重要.
  • 分子水凝为有针对性的生物医学干预提供了潜力.
  • 开发用于血小板抑制的选择性药物是一个重要的治疗目标.

研究的目的:

  • 为了研究三化水凝器,Nap-FFG在血小板表面的选择性自我组装.
  • 为了评估Nap-FFG的抗血小板聚合功效.
  • 探索Nap-FFG在更广泛的生物医学应用中的潜力.

主要方法:

  • 三化水凝器的合成和表征.
  • 在体外测定抑制血小板聚合的试验 (ADP,原蛋白,血,酸).
  • 使用LC-MS,共聚焦显微镜和冷TEM进行表面分析.
  • 测量泽塔潜力的测量.
  • 使用NIH 3T3细胞进行细胞表面结合研究.

主要成果:

  • 纳普-FFG在人体血小板上选择性地自我组装,抑制具有低IC50值的各种聚合途径.
  • 其他NAP-FFX类似物显著减少或完全没有抑制活性.
  • 化TEM揭示了Nap-FFG处理的血小板周围的自我组装的纳米纤维.
  • 与NIH 3T3细胞相比,Nap-FFG对血小板的亲和力更高,表明有选择性的结合.
  • 通过Nap-FFG观察到血小板的表面水凝.

结论:

  • 纳普-FFG作为选择性的血小板表面水凝器,通过未知的联体受体相互作用有效抑制血小板聚合.
  • 这一发现扩大了分子水凝在生物医学应用中的实用性.
  • 纳普-FFG为潜在的治疗干预提出了一个新的策略,包括通过病原体表面水凝来对抗传染病.